<DOC>
	<DOCNO>NCT00271271</DOCNO>
	<brief_summary>Primary : ·To evaluate activity combination gemcitabine , oxaliplatin vinorelbine first line treatment patient non-small cell bronchopulmonary cancer Secondary : ·To evaluate toxicity combination</brief_summary>
	<brief_title>Efficacy Study GEMOX Combination Vinorelbine NSCL Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Nonsmall cell bronchopulmonary cancer establish histological and/or cytological method ; Advanced metastatic disease ( stage IIIB IV ) ; At least one measurable lesion one dimension ( &gt; = 20 mm CT scan &gt; =10 mm CT scan ) outside irradiated area ; No prior chemotherapy ; Previous radiotherapy permit long washout period least 4 week ; Age &gt; = 18 year old ; ECOG Performance Status ( PS ) : 01 ; Life expectancy &gt; 3 month ; Hepatic renal function blood count satisfactory : Blood count : white blood cell &gt; = 3.0 x 10^9/l , neutrophil &gt; = 1.5 x 10^9/l , platelet &gt; = 150 x 10^9/l , haemoglobin &gt; = 9 g/dl , Hepatic function : bilirubin within limit normal upper value , aspartate transaminase ( AST ) alanine transaminase ( ALT ) &lt; = 2.5 time normal upper value Renal function : creatinine clearance ( calculate accord Cockroft Gault ) &gt; = 40 ml/min ; Patients reproductive age must use effective contraceptive method ; Informed consent form sign procedure undertaken connect study Pregnant breastfeeding patient ; Past record cancer ( exclude basocellular epidermoid cutaneous carcinoma cure carcinoma cervix ) ; Symptomatic cerebral leptomeningeal metastasis ; Symptomatic peripheral neuropathy &gt; 1 ( NCICTC grade ) ; Presence serious disease medical condition incompatible study ( discretion investigator ) ; Treatment another test product participation another therapeutic trial 4 week precede inclusion study ; Concomitant treatment anticancer therapy ; Concomitant treatment phenytoin . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>